COTINGA PHARMACEUTICALS

Critical Outcome Technologies Inc. (COTI) believes that there must be a better way to get safe and effective new drug therapies to people in need on a more timely, cost effective and efficient manner. Their business is disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. COTI is focused on the discovery and pre-clinical development of small molecules for the treatment of serious diseases for which current therapy is either lacking or ineffective.